Professor Emeritus, Surgery; Surgical Oncology, UCLA School of Medicine
General Surgery
Dr. Donald L. Morton, MD
Doctor Donald L. Morton, MD practices General Surgery. He researched medicine at University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is one of the top medical schools in the US. University of California San Francisco School of Medicine is ranked 3/3 in Research/PrimaryCare. He received 1 awards: "Fellow (FACS)". Donald L. Morton is a published doctor. He has 101 publications published. The most current publication "Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome."
Publications
- Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome.
- DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations.
- Final trial report of sentinel-node biopsy versus nodal observation in melanoma.
- Age as a Predictor of Sentinel Node Metastasis among Patients with Localized Melanoma: An Inverse Correlation of Melanoma Mortality and Incidence of Sentinel Node Meta...
- The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma.
- Late recurrence in melanoma: clinical implications of lost dormancy.
- Age as a prognostic factor in patients with localized melanoma and regional metastases.
- Staging of Regional Lymph Nodes in Melanoma: A Case for Including Nonsentinel Lymph Node Positivity in the American Joint Committee on Cancer Staging System.
- B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma.
- BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.
- Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicen...
- Preoperative imaging of pulmonary metastases in patients with melanoma: implications for minimally invasive techniques.
- Epitrochlear sentinel lymph nodes in melanoma: interval or independent?
- AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.
- Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma.
- Assessment of Prognostic Circulating Tumor Cells in a Phase III Trial of Adjuvant Immunotherapy After Complete Resection of Stage IV Melanoma.
- Staging of Regional Nodes in Pulmonary Malignancies.
- Redirected Lysis of Human Melanoma Cells by a MCSP/CD3-bispecific BiTE Antibody That Engages Patient-derived T Cells.
- Melanoma: Are we there yet?
- Reply to Letter to the Editor "Lymphoedema in the Observation and Biopsy Arms of MSLT-1" by Thomas, J Meirion (ASO-2011-04-0666).
- Unique patterns of metastases in common and rare types of malignancy.
- Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer ...
- Management of popliteal sentinel nodes in melanoma.
- Does metastasectomy improve survival in patients with stage IV melanoma? a cancer registry analysis of outcomes.
- Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma.
- Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patients.
- Sentinel node biopsy in melanoma: technical considerations of the procedure as performed at the John Wayne Cancer Institute.
- Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases.
- Predictors of occult nodal metastasis in patients with thin melanoma.
- Practice patterns and outcomes for anorectal melanoma in the USA, reviewing three decades of treatment: is more extensive surgical resection beneficial in all patients?
- Aberrant fatty acid-binding protein-7 gene expression in cutaneous malignant melanoma.
- Final version of 2009 AJCC melanoma staging and classification.
- Effect of granulocyte/macrophage colony-stimulating factor on vaccination with an allogeneic whole-cell melanoma vaccine.
- Biological factors, tumor growth kinetics, and survival after metastasectomy for pulmonary melanoma.
- Improved survival for stage IV melanoma from an unknown primary site.
- Age-related lymphatic dysfunction in melanoma patients.
- Sentinel node biopsy and standard of care for melanoma.
- mRNA expression and BRAF mutation in circulating melanoma cells isolated from peripheral blood with high molecular weight melanoma-associated antigen-specific monoclon...
- Solitary dermal melanoma: beginning or end of the metastatic process?
- CpG island methylator phenotype predicts progression of malignant melanoma.
- Activation of Toll-like receptors 2, 3, and 4 on human melanoma cells induces inflammatory factors.
- Importance of sentinel lymph node biopsy in patients with thin melanoma.
- Management decisions for nodal metastasis from an unknown primary melanoma.
- Human high molecular weight-melanoma-associated antigen: utility for detection of metastatic melanoma in sentinel lymph nodes.
- Sentinel node biopsy: facts to clear the alleged clouds.
- Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma.
- Activation of CCR9/CCL25 in cutaneous melanoma mediates preferential metastasis to the small intestine.
- Surgery and sentinel lymph node biopsy.
- Monocyte-derived IL-10 expression predicts prognosis of stage IV melanoma patients.
- Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma.
- Prognostic impact of micrometastases in colon cancer: interim results of a prospective multicenter trial.
- In honor of Alfred Schutt Ketcham, M.D.
- Can completion lymph node dissection be avoided for a positive sentinel node in melanoma?
- A Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients.
- Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma.
- Significance of endogenous augmentation of antiganglioside IgM in cancer patients: potential tool for early detection and management of cancer therapy.
- Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
- Authors' response to a letter to the editor re: Sentinel node biopsy for early-stage melanoma.
- Immunogenic gangliosides in human ovarian carcinoma.
- The role of sentinel lymph node biopsy in the management of melanoma.
- Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.
- Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
- Estrogen receptor-alpha methylation predicts melanoma progression.
- Melanoma patients with positive sentinel nodes who did not undergo completion lymphadenectomy: a multi-institutional study.
- Prospective multicenter trial of staging adequacy in colon cancer: preliminary results.
- The promise of metastasectomy in melanoma.
- Can surgical therapy alone achieve long-term cure of melanoma metastatic to regional nodes?
- Detection of clinically relevant melanoma metastases requires focused, not exhaustive, evaluation of sentinel lymph nodes.
- Microphthalmia transcription factor as a molecular marker for circulating tumor cell detection in blood of melanoma patients.
- Survivin expression by metastatic melanoma predicts poor disease outcome in patients receiving adjuvant polyvalent vaccine.
- Endogenous immune response to gangliosides in patients with confined prostate cancer.
- Immunotherapy today: the story of a vaccine.
- Melanoma recurrence patterns after negative sentinel lymphadenectomy.
- Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.
- Human antiganglioside autoantibodies: validation of ELISA.
- Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.
- Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer.
- Peripheral blood CD4+ T-cell response before postoperative active immunotherapy correlates with clinical outcome in metastatic melanoma.
- Factors predictive of tumor-positive nonsentinel lymph nodes after tumor-positive sentinel lymph node dissection for melanoma.
- Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells.
- Contemporary surgical treatment of advanced-stage melanoma.
- Lymphatic mapping and sentinel lymphadenectomy for primary and metastatic pulmonary malignant neoplasms.
- Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node.
- Prognostic significance of molecular upstaging of paraffin-embedded sentinel lymph nodes in melanoma patients.
- Detection of differentially expressed proteins in early-stage melanoma patients using SELDI-TOF mass spectrometry.
- An evidence-based staging system for cutaneous melanoma.
- Allelic imbalance of 12q22-23 associated with APAF-1 locus correlates with poor disease outcome in cutaneous melanoma.
- Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas.
- Sentinel node mapping and an International Sentinel Node Society: current issues and future directions.
- Prolonged survival after complete resection of metastases from intraocular melanoma.
- Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic fac...
- Melanoma-inhibiting activity assay predicts survival in patients receiving a therapeutic cancer vaccine after complete resection of American Joint Committee on Cancer ...
- The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making.
- Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine.
- Is sentinel lymph node mapping indicated for isolated local and in-transit recurrent melanoma?
- Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes.
- Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving...
- Differential expression of thymidylate synthase in colorectal tumors and matched lymph nodes: impact on adjuvant treatment.
- Molecular tumor markers in the blood: early prediction of disease outcome in melanoma patients treated with a melanoma vaccine.
- Serum total ganglioside level correlates with clinical course in melanoma patients after immunotherapy with therapeutic cancer vaccine.
Schools
University Of California San Francisco School Of Medicine
Uc San Francisco
Doctors Specialties
- General Surgery
- Thoracic Surgery
Accepted Insurances
Awards
- Fellow (FACS)
Education
-
UCSF -
University of California San Francisco School of Medicine
Hospital
-
Ronald Reagan UCLA Medical Center
Helpful Reviews
Similar Doctors
|
Dr. Mark B. Faries, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jay A. Jensen, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marjorie B. Fine, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Harvey Deutsch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Camelia A. Lawrence, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Anton Bilchik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larry T. Khoo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David T. Sung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Seibert, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sigrid K. Burruss, MD |
|
|
Dr. Connie G. Chiu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel D. Kirchoff, MD
This Doctor is OpenDoctor Recommended.
|